Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
7.33
0.56 (8.27%)
At close: Aug 15, 2025, 3:59 PM
7.30
-0.48%
After-hours: Aug 15, 2025, 07:20 PM EDT

Jade Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-5.43M -16.87M -24.77M -23.19M -20.41M -19.56M
Depreciation & Amortization
8K n/a 28K 28K 28K 25K
Stock-Based Compensation
n/a 27K n/a n/a n/a n/a
Other Working Capital
-5.88M 8.04M 193K -4.79M 4.32M 3.51M
Other Non-Cash Items
943.22K 1.7M 3.17M 3.44M 2.31M 2.43M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-6.57M 8.34M 1.14M -3.96M 3.27M 1.5M
Operating Cash Flow
-11.05M -6.8M -20.43M -23.67M -14.8M -15.61M
Capital Expenditures
n/a n/a n/a n/a -64K -32K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a -4.93M n/a -14.75M -27.79M -47.85M
Sales Maturities Of Investments
13.13M 21M 18M 23.58M 33.5M 34.75M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a
Investing Cash Flow
13.13M 16.07M 18M 8.83M 5.65M -13.13M
Debt Repayment
n/a 95M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -250K n/a n/a n/a n/a
Financial Cash Flow
554K 94.77M 24.38M 471K 463K 20K
Net Cash Flow
2.64M 87.97M 21.95M -14.37M -8.69M -28.72M
Free Cash Flow
-11.05M -6.8M -20.43M -23.67M -14.86M -15.64M